Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe ...

AstraZeneca may be emphasizing the potential for combination treatments to help its obesity pipeline stand out from the crowd, but the Big Pharma insists it is still “playing to win” in the space.

AstraZeneca Plc said its experimental obesity pill was well tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines. The ...

Dakota Wealth Management cut its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 1.8% in the 3rd quarter, ...

I am not going to worry about which side of the aisle an idea comes from, or wait for marching orders from the party bosses ...

BALTIMORE - Abortion rights are front and center on the 2024 Maryland election ballot with Question 1. Abortion is legal in Maryland. However, state lawmakers last year passed an amendment that ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The president of AstraZeneca’s China division has been placed under investigation by local police, as Beijing advances an anti-corruption crackdown in the healthcare sector. The British ...

October is Breast Cancer Awareness Month, and we're teaming up with AstraZeneca to bring you life-saving conversations on ...

BEIJING—An investigation involving a top executive at drugmaker AstraZeneca AZN-8.40%decrease; red down pointing triangle is the latest to rattle foreign companies in China, where a series of ...

As AstraZeneca’s chronic obstructive pulmonary disease drug Breztri continues climbing toward blockbuster status, the Big Pharma is broadening its efforts to support people with COPD.

Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of tirzepatide ...